Rothschild Investment LLC’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.6K Buy
353
+323
+1,077% +$11.6K ﹤0.01% 1798
2026
Q1
$1.06K Sell
30
-9
-23% -$366 ﹤0.01% 2844
2025
Q4
$1.58K Sell
39
-16
-29% -$696 ﹤0.01% 2481
2025
Q3
$2.59K Sell
55
-40
-42% -$2.07K ﹤0.01% 2070
2025
Q2
$4.95K Buy
95
+80
+533% +$4.39K ﹤0.01% 1517
2025
Q1
$906 Sell
15
-55
-79% -$3.54K ﹤0.01% 2394
2024
Q4
$4.79K Buy
70
+35
+100% +$2.44K ﹤0.01% 1357
2024
Q3
$2.52K Buy
35
+20
+133% +$1.41K ﹤0.01% 1611
2024
Q2
$1.04K Buy
15
+10
+200% +$729 ﹤0.01% 1638
2024
Q1
$400 Buy
+5
New +$446 ﹤0.01% 1442

Other funds holding CNMD

Rothschild Investment LLC's CNMD Position: Q2 2026 in Review

Rothschild Investment LLC increased its CONMED (CNMD) stake by 1,077% in Q2 2026, buying an estimated $11.6K and bringing the position to 353 shares worth $11.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1798.

Rothschild Investment LLC first reported a position in CNMD in Q1 2024 and has held it in 10 quarters since. 92 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Rothschild Investment LLC held 353 shares of CONMED worth $11.6K as of Q2 2026.
  • Rothschild Investment LLC bought 323 CONMED shares in Q2 2026, an estimated $11.6K.
  • CONMED made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #1798 holding.
  • Rothschild Investment LLC first reported a position in CONMED in Q1 2024 and has held it in 10 quarters since.
  • 92 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.